Philip J. Larsen

13.0k total citations · 2 hit papers
158 papers, 10.8k citations indexed

About

Philip J. Larsen is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Philip J. Larsen has authored 158 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Endocrine and Autonomic Systems, 70 papers in Cellular and Molecular Neuroscience and 43 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Philip J. Larsen's work include Neuropeptides and Animal Physiology (61 papers), Regulation of Appetite and Obesity (54 papers) and Neuroendocrine regulation and behavior (38 papers). Philip J. Larsen is often cited by papers focused on Neuropeptides and Animal Physiology (61 papers), Regulation of Appetite and Obesity (54 papers) and Neuroendocrine regulation and behavior (38 papers). Philip J. Larsen collaborates with scholars based in Denmark, United Kingdom and United States. Philip J. Larsen's co-authors include Niels Vrang, Mads Tang‐Christensen, Jens D. Mikkelsen, Peter Lommer Kristensen, Søren P. Sheikh, Jens J. Holst, Rüdiger Göke, David S. Jessop, Jes Thorn Clausen and Cathrine Ørskov and has published in prestigious journals such as Nature, Circulation and Journal of Clinical Investigation.

In The Last Decade

Philip J. Larsen

157 papers receiving 10.6k citations

Hit Papers

Hypothalamic CART is a new anorectic peptide regulated by... 1997 2026 2006 2016 1998 1997 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hypothalamic CART is a new anorectic peptide regulated by leptin
    1998 1.0k citations Peter Lommer Kristensen, Per Bo Jensen et al. profile →
  2. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem
    1997 539 citations Philip J. Larsen, Mads Tang‐Christensen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip J. Larsen Denmark 56 5.5k 3.3k 2.9k 2.7k 2.5k 158 10.8k
Jacques Epelbaum France 64 3.7k 0.7× 4.1k 1.3× 3.0k 1.0× 3.3k 1.2× 4.0k 1.6× 307 13.1k
Ronald M. Lechan United States 62 5.0k 0.9× 2.7k 0.8× 2.2k 0.7× 4.1k 1.5× 1.9k 0.8× 212 11.7k
Toshihiko Yada Japan 57 5.9k 1.1× 2.1k 0.6× 3.3k 1.1× 1.9k 0.7× 2.7k 1.1× 260 11.6k
Julie A. Chowen Spain 54 3.2k 0.6× 1.7k 0.5× 2.3k 0.8× 2.7k 1.0× 1.5k 0.6× 220 9.2k
Niels Vrang Denmark 48 4.1k 0.7× 1.6k 0.5× 2.7k 0.9× 2.5k 0.9× 1.7k 0.7× 144 8.3k
Gregory J. Morton United States 48 6.6k 1.2× 1.2k 0.4× 5.1k 1.8× 1.3k 0.5× 2.4k 1.0× 108 12.3k
Charles V. Mobbs United States 44 3.7k 0.7× 1.1k 0.3× 3.0k 1.0× 1.1k 0.4× 1.7k 0.7× 146 8.4k
Sabrina Diano United States 55 8.5k 1.5× 1.6k 0.5× 5.5k 1.9× 1.3k 0.5× 2.6k 1.0× 130 14.1k
Brian J. Oldfield Australia 52 3.4k 0.6× 1.5k 0.5× 2.1k 0.7× 1.0k 0.4× 1.5k 0.6× 156 8.1k
Laurence H. Tecott United States 49 2.2k 0.4× 3.9k 1.2× 1.9k 0.7× 691 0.3× 3.4k 1.3× 78 9.8k

Countries citing papers authored by Philip J. Larsen

Since Specialization
Citations

This map shows the geographic impact of Philip J. Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Larsen more than expected).

Fields of papers citing papers by Philip J. Larsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Larsen. The network helps show where Philip J. Larsen may publish in the future.

Co-authorship network of co-authors of Philip J. Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Larsen. A scholar is included among the top collaborators of Philip J. Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Larsen. Philip J. Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2021). Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes. Journal of Nuclear Medicine. 63(5). jnumed.121.262506–jnumed.121.262506. 6 indexed citations
2.
Raichur, Suryaprakash, Bodo Brunner, Maximilian Bielohuby, et al.. (2019). The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. Molecular Metabolism. 21. 36–50. 143 indexed citations
3.
Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations
4.
Lykkegaard, Kirsten, Philip J. Larsen, Niels Vrang, et al.. (2008). The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance. Schizophrenia Research. 103(1-3). 94–103. 45 indexed citations
5.
Larsen, Philip J., Kirsten Lykkegaard, Leif K. Larsen, et al.. (2008). Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone. European Journal of Pharmacology. 596(1-3). 173–179. 34 indexed citations
6.
Tankó, László B., Afshan Siddiq, Cécile Lecœur, et al.. (2005). ACDC/Adiponectin and PPAR‐γ Gene Polymorphisms: Implications for Features of Obesity. Obesity Research. 13(12). 2113–2121. 50 indexed citations
7.
Ye, Ji‐Ming, Miguel A. Iglesias, David G. Watson, et al.. (2003). PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. American Journal of Physiology-Endocrinology and Metabolism. 284(3). E531–E540. 131 indexed citations
8.
Larsen, Philip J., Niels Vrang, Mads Tang‐Christensen, et al.. (2002). Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides. European Journal of Pharmacology. 440(2-3). 159–172. 17 indexed citations
9.
Hay‐Schmidt, Anders, Lone Helboe, & Philip J. Larsen. (2001). Leptin Receptor Immunoreactivity Is Present in Ascending Serotonergic and Catecholaminergic Neurons of the Rat. Neuroendocrinology. 73(4). 215–226. 61 indexed citations
10.
Larsen, Philip J.. (1999). Tracing autonomic innervation of the rat pineal gland using viral transneuronal tracing. Microscopy Research and Technique. 46(4-5). 296–304. 15 indexed citations
11.
Tejedor‐Real, P., et al.. (1998). A Differential Response to Stress is not a Prediction of Susceptibility or Severity in Adjuvant-Induced Arthritis. Stress. 2(3). 221–226. 15 indexed citations
12.
Larsen, Philip J. & Niels Vrang. (1995). Neurones projecting to the hypothalamus from the brainstem A1 catecholaminergic cell group express glutamate-R2,3 receptor immunoreactivity. Brain Research. 705(1-2). 209–215. 3 indexed citations
13.
Chowdrey, H.S., Philip J. Larsen, Michael S. Harbuz, et al.. (1995). Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant‐induced arthritis. British Journal of Pharmacology. 116(5). 2417–2424. 100 indexed citations
14.
Göke, Rüdiger, Philip J. Larsen, Jens D. Mikkelsen, & Søren P. Sheikh. (1995). Identification of Specific Binding Sites for Glucagon-Like Peptide-1 on the Posterior Lobe of the Rat Pituitary. Neuroendocrinology. 62(2). 130–134. 50 indexed citations
15.
Woldbye, David P.D., et al.. (1994). Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Molecular Brain Research. 23(4). 317–322. 76 indexed citations
16.
Larsen, Philip J., David S. Jessop, Stafford L. Lightman, & Hardial S. Chowdrey. (1993). Preprotachykinin a gene expression in distinct hypothalamic and brain stem regions of the rat is affected by a chronic osmotic stimulus: A combined immunohistochemical and in situ hybridization histochemistry study. Brain Research Bulletin. 30(5-6). 535–545. 20 indexed citations
17.
Larsen, Philip J.. (1992). Distribution of substance P‐immunoreactive elements in the preoptic area and the hypothalamus of the rat. The Journal of Comparative Neurology. 316(3). 287–313. 72 indexed citations
18.
Larsen, Philip J., David S. Jessop, Hardial S. Chowdrey, Jens D. Mikkelsen, & Stafford L. Lightman. (1992). Osmotic regulation of substance P and neurokinin A peptide content and substance P binding sites in distinct hypothalamic nuclei of the rat. Peptides. 13(4). 705–712. 25 indexed citations
19.
Larsen, Philip J., David S. Jessop, Hardial S. Chowdrey, & Stafford L. Lightman. (1992). Neuropeptide Y messenger ribonucleic acid in the magnocellular hypothalamo-neurohypophysial system of the rat is increased during osmotic stimulation. Neuroscience Letters. 138(1). 23–26. 22 indexed citations
20.
Larsen, Philip J., Jens D. Mikkelsen, & Torben Særmark. (1989). Binding of a Iodinated Substance P Analog to a NK-1 Receptor on Isolated Cell Membranes from Rat Anterior Pituitary*. Endocrinology. 124(5). 2548–2557. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Epelbaum Breakdown of academic impact, for papers by Ronald M. Lechan Breakdown of academic impact, for papers by Toshihiko Yada Breakdown of academic impact, for papers by Julie A. Chowen Breakdown of academic impact, for papers by Niels Vrang Breakdown of academic impact, for papers by Gregory J. Morton Breakdown of academic impact, for papers by Charles V. Mobbs Breakdown of academic impact, for papers by Sabrina Diano Breakdown of academic impact, for papers by Brian J. Oldfield Breakdown of academic impact, for papers by Laurence H. Tecott
Rankless by CCL
2026